Latest News in the pharma Industry

Market News

Catalent boosts its global OTC and prescription softgel capabilities and capacity

Catalent boosts its global OTC and prescription softgel capabilities and capacity

28 Nov 2016

Company acquires two state-of-the-art facilities offering integrated softgel development, manufacturing and packaging.

Read more 
New software platform to control the cryogenic cold chain for cellular therapies

New software platform to control the cryogenic cold chain for cellular therapies

28 Nov 2016

Enables standardization and audit of remote freezing and thawing.

Read more 
Mylan agrees to produce and market generic version of BMS's Daklimza in developing countries

Mylan agrees to produce and market generic version of BMS's Daklimza in developing countries

28 Nov 2016

The license allows Mylan to develop fixed-dose combinations that offer the potential to treat all of the six major genotypes of hepatitis C virus.

Read more 
IL-17 inhibitors will drive psoriatic arthritis market to $12.6 billion by 2025

IL-17 inhibitors will drive psoriatic arthritis market to $12.6 billion by 2025

27 Nov 2016

The increase in diagnosed prevalent cases and the launches of interleukin (IL)-17 inhibitors, such as Eli Lilly’s Taltz and AstraZeneca’s Lumicef, will drive the market.

Read more 
Indian pharma companies forecast 30% growth in 2017 at CPhI India

Indian pharma companies forecast 30% growth in 2017 at CPhI India

24 Nov 2016

Domestic sales identified as chief driver behind unexpected rise in revenues.

Read more 
Non-small cell lung cancer market to gain over $20 billion in value by 2025

Non-small cell lung cancer market to gain over $20 billion in value by 2025

24 Nov 2016

It's anticipated that 65% of the total NSCLC market will go to immuno-oncology therapies.

Read more 
European Commission approves BMS's Opdivo for Hodgkin's

European Commission approves BMS's Opdivo for Hodgkin's

24 Nov 2016

Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union.

Read more 
Allergan boosts its CNS pipeline with acquisition

Allergan boosts its CNS pipeline with acquisition

23 Nov 2016

Chase acquisition adds a new Phase III ready program for Alzheimer's disease to Allergan portfolio.

Read more 
NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK

NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK

23 Nov 2016

Pomalidomide available to people in England immediately via the Cancer Drugs Fund.

Read more 
Future healthcare funding sources - heaven sent?

Future healthcare funding sources - heaven sent?

23 Nov 2016

Many companies embracing alternative funding sources, such as angel investors, as investments from VC firms continue to decrease.

Read more 
New asthma treatments on the horizon?

New asthma treatments on the horizon?

22 Nov 2016

Studies suggest calcilytics may represent effective future asthma therapeutics.

Read more 
Hikma and Vectura sign agreement to develop generic salmeterol

Hikma and Vectura sign agreement to develop generic salmeterol

22 Nov 2016

The asthma and COPD treatment will be delivered using Vectura’s proprietary dry powder inhalation technology and device.

Read more